{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:36:27Z","timestamp":1791146187360,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3014,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Hepatitis C virus (HCV) replication is highly dependent on host cell factors. Identification of these host factors not only facilitates understanding of the biology of HCV infection but also enables the discovery of novel targets for anti-HCV therapy. To identify host genes important for HCV RNA replication, we screened a library of small interfering RNA (siRNA) that targets approximately 4,000 human genes in Huh7-derived EN5-3 cells harboring an HCV subgenomic replicon with the nonstructural region NS3-NS5B from the 1b-N strain. Nine cellular genes that potentially regulate HCV replication were identified in this screen. Silencing of these genes resulted in inhibition of HCV replication by more than 60% and exhibited minimal toxicity. Knockdown of host gene expression by these siRNAs was confirmed at the RNA level and, in some instances, at the protein level. The level of siRNA silencing of these host genes correlated well with inhibition of HCV. These genes included those that encoded a G-protein coupled receptor (<\/jats:bold>\n                                 <jats:bold>\n                                    TBXA2R\n                                 <\/jats:bold>\n                                 <jats:bold>), a membrane protein (<\/jats:bold>\n                                 <jats:bold>\n                                    LT\u03b2\n                                 <\/jats:bold>\n                                 <jats:bold>), an adapter protein (<\/jats:bold>\n                                 <jats:bold>\n                                    TRAF2\n                                 <\/jats:bold>\n                                 <jats:bold>), 2 transcription factors (<\/jats:bold>\n                                 <jats:bold>\n                                    RelA\n                                 <\/jats:bold>\n                                 <jats:bold>and<\/jats:bold>\n                                 <jats:bold>\n                                    NF\u03baB2\n                                 <\/jats:bold>\n                                 <jats:bold>), 2 protein kinases (<\/jats:bold>\n                                 <jats:bold>\n                                    MKK7\n                                 <\/jats:bold>\n                                 <jats:bold>and<\/jats:bold>\n                                 <jats:bold>\n                                    SNARK\n                                 <\/jats:bold>\n                                 <jats:bold>), and 2 closely related transporter proteins (<\/jats:bold>\n                                 <jats:bold>\n                                    SLC12A4\n                                 <\/jats:bold>\n                                 <jats:bold>and<\/jats:bold>\n                                 <jats:bold>\n                                    SLC12A5\n                                 <\/jats:bold>\n                                 <jats:bold>). Of interest, some of these genes are members of the tumor necrosis factor\/lymphotoxin signaling pathway.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>Findings of this study may provide important information for understanding HCV replication. In addition, these cellular genes may constitute a novel set of targets for HCV antiviral therapy. (Hepatology 2007.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21608","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T00:18:59Z","timestamp":1179965939000},"page":"1413-1421","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":111,"title":["Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology"],"prefix":"10.1097","volume":"45","author":[{"given":"Teresa I.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"Pilot-Matias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennadiy","family":"Koev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Pithawalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Dekhtyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schurdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhteruzzaman","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends.","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"Suppl","key":"R2-13-20241201","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C.","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"R3-13-20241201","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/emboj\/19.4.729","article-title":"Hepatitis C virus core proteininduced loss of LZIP function correlates with cellular transformation.","volume":"19","author":"Jin","year":"2000","journal-title":"Embo J"},{"key":"R4-13-20241201","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1128\/jvi.71.11.8856-8859.1997","article-title":"Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.","volume":"71","author":"Kato","year":"1997","journal-title":"J Virol"},{"key":"R5-13-20241201","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1128\/JVI.80.9.4372-4379.2006","article-title":"Hepatitis C virus core protein inhibits tumor necrosis factor alphamediated apoptosis by a protective effect involving cellular FLICE inhibitory protein.","volume":"80","author":"Saito","year":"2006","journal-title":"J Virol"},{"key":"R6-13-20241201","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1074\/jbc.M312245200","article-title":"The Hepatitis C virus NS5A protein activates a phosphoinositide 3kinasedependent survival signaling cascade.","volume":"279","author":"Street","year":"2004","journal-title":"J Biol Chem"},{"key":"R7-13-20241201","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1073\/pnas.96.10.5533","article-title":"NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptorbound protein 2 adaptor protein in a Src homology 3 domainliganddependent manner and perturbs mitogenic signaling.","volume":"96","author":"Tan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-13-20241201","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.20012127","article-title":"Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation.","volume":"196","author":"Yoshida","year":"2002","journal-title":"J Exp Med"},{"issue":"Suppl","key":"R9-13-20241201","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C.","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"key":"R10-13-20241201","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1089-3261(02)00078-8","article-title":"Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.","volume":"7","author":"Seeff","year":"2003","journal-title":"Clin Liver Dis"},{"key":"R11-13-20241201","doi-asserted-by":"crossref","first-page":"39260","DOI":"10.1074\/jbc.M506407200","article-title":"Binding site characterization and resistance to a class of nonnucleoside inhibitors of the hepatitis C virus NS5B polymerase.","volume":"280","author":"Kukolj","year":"2005","journal-title":"J Biol Chem"},{"key":"R12-13-20241201","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.","volume":"426","author":"Lamarre","year":"2003","journal-title":"Nature"},{"key":"R13-13-20241201","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1128\/AAC.50.5.1813-1822.2006","article-title":"VX950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells.","volume":"50","author":"Lin","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-13-20241201","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/AAC.50.3.1013-1020.2006","article-title":"SCH 503034, a mechanismbased inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells.","volume":"50","author":"Malcolm","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-13-20241201","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/AAC.49.10.4305-4314.2005","article-title":"Mutations conferring resistance to a hepatitis C virus (HCV) RNAdependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.","volume":"49","author":"Mo","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-13-20241201","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M510195200","article-title":"The novel nucleoside analog R1479 (4azidocytidine) is a potent inhibitor of NS5Bdependent RNA synthesis and hepatitis C virus replication in cell culture.","volume":"281","author":"Klumpp","year":"2006","journal-title":"J Biol Chem"},{"key":"R17-13-20241201","doi-asserted-by":"crossref","first-page":"36784","DOI":"10.1074\/jbc.M506462200","article-title":"In vitro studies of crossresistance mutations against two hepatitis C virus serine protease inhibitors, VX950 and BILN 2061.","volume":"280","author":"Lin","year":"2005","journal-title":"J Biol Chem"},{"key":"R18-13-20241201","doi-asserted-by":"crossref","first-page":"17508","DOI":"10.1074\/jbc.M313020200","article-title":"In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX950 and BILN 2061: structural analysis indicates different resistance mechanisms.","volume":"279","author":"Lin","year":"2004","journal-title":"J Biol Chem"},{"key":"R19-13-20241201","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.48.6.2260-2266.2004","article-title":"Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro.","volume":"48","author":"Lu","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-13-20241201","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2005.12.003","article-title":"Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034.","volume":"70","author":"Tong","year":"2006","journal-title":"Antiviral Res"},{"key":"R21-13-20241201","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1074\/jbc.M510246200","article-title":"Mutations conferring resistance to SCH6, a novel hepatitis C virus NS34A protease inhibitor. Reduced RNA replication fitness and partial rescue by secondsite mutations.","volume":"281","author":"Yi","year":"2006","journal-title":"J Biol Chem"},{"key":"R22-13-20241201","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.virol.2006.03.045","article-title":"In vitro selected Con1 subgenomic replicons resistant to 2CMethylCytidine or to R1479 show lack of cross resistance.","volume":"351","author":"Le Pogam","year":"2006","journal-title":"Virology"},{"key":"R23-13-20241201","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1128\/JVI.02628-05","article-title":"Selection and characterization of replicon variants dually resistant to thumb and palmbinding nonnucleoside polymerase inhibitors of the hepatitis C virus.","volume":"80","author":"Le Pogam","year":"2006","journal-title":"J Virol"},{"key":"R24-13-20241201","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.2002.1652","article-title":"Subgenomic hepatitis C virus replicons inducing expression of a secreted enzymatic reporter protein.","volume":"304","author":"Yi","year":"2002","journal-title":"Virology"},{"key":"R25-13-20241201","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/JVI.77.5.3181-3190.2003","article-title":"Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture.","volume":"77","author":"Blight","year":"2003","journal-title":"J Virol"},{"key":"R26-13-20241201","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1074\/jbc.M212602200","article-title":"Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase.","volume":"278","author":"Grobler","year":"2003","journal-title":"J Biol Chem"},{"key":"R27-13-20241201","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1073\/pnas.171319698","article-title":"Hepatitis C virus replication is directly inhibited by IFNalpha in a fulllength binary expression system.","volume":"98","author":"Chung","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-13-20241201","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1073\/pnas.252783999","article-title":"Interference of hepatitis C virus RNA replication by short interfering RNAs.","volume":"100","author":"Kapadia","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-13-20241201","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/JVI.77.1.810-812.2003","article-title":"Small interfering RNAmediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh7.","volume":"77","author":"Seo","year":"2003","journal-title":"J Virol"},{"key":"R30-13-20241201","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/AAC.45.6.1629-1636.2001","article-title":"Selection and characterization of varicellazoster virus variants resistant to (R)94hydroxy2(hydroxymethy)butylguanine.","volume":"45","author":"Ng","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-13-20241201","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2005.03.006","article-title":"Screening for hepatitis C virus antiviral activity with a cellbased secreted alkaline phosphatase reporter replicon system.","volume":"67","author":"Bourne","year":"2005","journal-title":"Antiviral Res"},{"key":"R32-13-20241201","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","article-title":"Activation of the interferon system by shortinterfering RNAs.","volume":"5","author":"Sledz","year":"2003","journal-title":"Nat Cell Biol"},{"key":"R33-13-20241201","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1128\/JVI.79.7.3969-3978.2005","article-title":"Inhibition of RIGIdependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.","volume":"79","author":"Breiman","year":"2005","journal-title":"J Virol"},{"key":"R34-13-20241201","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.1082604","article-title":"Regulation of interferon regulatory factor3 by the hepatitis C virus serine protease.","volume":"300","author":"Foy","year":"2003","journal-title":"Science"},{"key":"R35-13-20241201","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS34A proteasemediated cleavage of the Tolllike receptor 3 adaptor protein TRIF.","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-13-20241201","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0105-2896.2004.00206.x","article-title":"Lymphotoxin and LIGHT signaling pathways and target genes.","volume":"202","author":"Schneider","year":"2004","journal-title":"Immunol Rev"},{"key":"R37-13-20241201","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep.20371","article-title":"Hepatitis C virus NS5Aregulated gene expression and signaling revealed via microarray and comparative promoter analyses.","volume":"40","author":"Girard","year":"2004","journal-title":"Hepatology"},{"key":"R38-13-20241201","doi-asserted-by":"crossref","first-page":"40778","DOI":"10.1074\/jbc.M303248200","article-title":"Hepatitis C virus NS5A and subgenomic replicon activate NFkappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease.","volume":"278","author":"Waris","year":"2003","journal-title":"J Biol Chem"},{"key":"R39-13-20241201","doi-asserted-by":"crossref","first-page":"13122","DOI":"10.1074\/jbc.M111599200","article-title":"Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alphastimulated nuclear factor kappa B activation.","volume":"277","author":"Park","year":"2002","journal-title":"J Biol Chem"},{"key":"R40-13-20241201","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1128\/jvi.71.12.9417-9426.1997","article-title":"Direct interaction of hepatitis C virus core protein with the cellular lymphotoxinbeta receptor modulates the signal pathway of the lymphotoxinbeta receptor.","volume":"71","author":"Chen","year":"1997","journal-title":"J Virol"},{"key":"R41-13-20241201","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/jvi.71.2.1301-1309.1997","article-title":"Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxinbeta receptor.","volume":"71","author":"Matsumoto","year":"1997","journal-title":"J Virol"},{"key":"R42-13-20241201","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0006-2952(02)01300-X","article-title":"Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ERnucleus signal transduction pathway and activates NFkappaB and STAT3.","volume":"64","author":"Waris","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"R43-13-20241201","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1073\/pnas.171311298","article-title":"Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT3 and NFkappa B.","volume":"98","author":"Gong","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-13-20241201","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2005.02.004","article-title":"Hepatitis C virus, ER stress, and oxidative stress.","volume":"13","author":"Tardif","year":"2005","journal-title":"Trends Microbiol"},{"key":"R45-13-20241201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.20001","article-title":"Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells.","volume":"39","author":"Choi","year":"2004","journal-title":"Hepatology"},{"key":"R46-13-20241201","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/sj.onc.1203174","article-title":"NFkappaB as a primary regulator of the stress response.","volume":"18","author":"Mercurio","year":"1999","journal-title":"Oncogene"},{"key":"R47-13-20241201","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1099\/vir.0.80204-0","article-title":"Hepatitis C virus NS5A: tales of a promiscuous protein.","volume":"85","author":"Macdonald","year":"2004","journal-title":"J Gen Virol"},{"key":"R48-13-20241201","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molimm.2004.11.007","article-title":"The role of Tolllike receptors in the host response to viruses.","volume":"42","author":"Bowie","year":"2005","journal-title":"Mol Immunol"},{"key":"R49-13-20241201","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1299.042","article-title":"Convergence of the NFkappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis.","volume":"1010","author":"Hiscott","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R50-13-20241201","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1128\/JVI.78.21.11865-11878.2004","article-title":"Calciumdependent calpain proteases are implicated in processing of the hepatitis C virus NS5A protein.","volume":"78","author":"Kalamvoki","year":"2004","journal-title":"J Virol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21608","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200706000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:20:50Z","timestamp":1733055650000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200706000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21608","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}